Microvascular damage and platelet abnormalities in early Alzheimer's disease

Journal of the Neurological Sciences

Volumn 203-204, Issue , 2002, Pages 189-193

  Borroni, Barbara ^a   Akkawi, Nabil ^a   Martini, Giuliana ^b   Colciaghi, Francesca ^c   Prometti, Paola ^b   Rozzini, Luca ^a   Di Luca, Monica ^c   Lenzi, Gian Luigi ^d   Romanelli, Giuseppe ^b   Caimi, Luigi ^b   Padovani, Alessandro ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Alzheimer disease; Endothelial dysfunction; Hemostasis changes; Platelets; Thrombomodulin

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; THROMBOMODULIN;

ACUTE DISEASE; ALZHEIMER DISEASE; BRAIN BLOOD FLOW; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFERENCE PAPER; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; ENDOTHELIUM LESION; GENETIC ASSOCIATION; HEMOSTASIS; HUMAN; MICROANGIOPATHY; MICROVASCULATURE; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN PROCESSING; RISK FACTOR; THROMBOCYTE; THROMBOCYTE ANOMALY; VASCULAR DISEASE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; BLOOD PLATELETS; CAPILLARIES; ENDOTHELIUM, VASCULAR; HUMANS;

EID: 0037111156     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(02)00289-7     Document Type: Conference Paper

References (34)

1. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 82:1991;239-259.
2. Hofman A., Ott A., Breteler M.M.et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 349:1997;151-154.
3. de la Torre J.C. Critical threshold cerebral hypoperfusion causes Alzheimer's disease? Acta Neuropathol. 98(1):1999;1-8.
4. Skoog I. The relationship between blood pressure and dementia: a review. Biomed. Pharmacother. 51(9):1997;367-375.
5. Jick H., Zornberg G.L., Jick S.S., Seshadri S., Drachman D.A. Statins and the risk of dementia. Lancet. 356:2000;1627-1631.
6. Contois J.H., Anamani D.E., Tsongalis G.J. The underlying molecular mechanism of apolipoprotein E polymorphism: relationships to lipid disorders, cardiovascular disease, and Alzheimer's disease. Clin. Lab. Med. 16(1):1996;105-123.
7. Kokmen E., Whisnant J.P., O'Fallon W.M.et al. Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984). Neurology. 46:1996;154-159.
8. Wolf D.S., Gearing M., Snowdon D.A.et al. Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun study. Alzheimer Dis. Assoc. Disord. 13(4):1999;226-231.
9. Snowdon D.A., Greiner L.H., Mortimer J.A., Riley K.P., Greiner P.A., Markersbery M.R. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA. 277(10):1997;813-817.
10. Kudo T., Imaizumi K., Tanimukai H.et al. Are cerebrovascular factors involved in Alzheimer's disease? Neurobiol. Aging. 21(2):2000;215-224.
11. Goldgaber D., Lerman M.I., McBride O.W., Saffiotti U., Gajdusek D.C. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science. 235:1987;877-880.
12. Tanzi R.E., Gusella J.F., Watkins P.C. Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science. 235:1987;880-884.
13. Selkoe D.J., Podlinsly M.B., Joakim C.L. Beta-amyloid precursor protein of Alzheimer's disease occurs as 110- to 135-kilodalton membrane associated proteins in neural and non-neural tissues. Proc. Natl. Acad. Sci. U. S. A. 85:1988;7341-7345.
14. Bush A.I., Martins R.N., Rumble B., Moir R., Fuller S., Milward E. The amyloid precursor protein of Alzheimer's disease is released by human platelets. J. Biol. Chem. 265:1990;15977-15983.
15. Smith R.P., Higuchi D.A., Broze G.J. Jr. Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein. Science. 248:1990;1126-1128.
16. Van Nostrand W.E., Schmaier A.H., Farrow J.S. Protease nexin II (amyloid β-protein precursor): a platelet β-granule protein. Science. 248:1990;745-748.
17. Oltersdorf T., Fritz L.C., Schenk D.B. The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin II. Nature. 341:1989;144-147.
18. Lammich S., Kojro E., Postina R.et al. Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by disintegrine metalloprotease. Proc. Natl. Acad. Sci. 96:1999;3922-3927.
19. Buxbaum J.D., Liu K.N., Luo Y.et al. Evidence that tumor necrosis factor alfa-converting enzyme is involved in regulated alfa-secretase cleavage of Alzheimer amyloid precursor protein. J. Biol. Chem. 273:1998;27765-27767.
20. Seubert P., Vigo-Pelfrey C., Esch F. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluid. Nature. 359:1998;325-327.
21. Sevush S., Horstman L.L., Mao W.W. Platelet activation in Alzheimer disease. Arch. Neurol. 55:1998;530-536.
22. Zubenko G.S. Platelet membrane fluidity. Neurology. 43:1993;234-236.
23. Matsushima H., Shimohama S., Fujimoto S.et al. Changes in platelet phospholipase C protein level and activity in Alzheimer's disease. Neurobiol. Aging. 16:1995;895-900.
24. Matsushima H., Shimohama S., Tanaka S.et al. Platelet protein kinase C levels in Alzheimer's disease. Neurobiol. Aging. 15:1994;671-674.
25. Di Luca M., Pastorino L., Cattabeni F.et al. Abnormal pattern of platelet APP isoforms in Alzheimer disease and down syndrome. Arch. Neurol. 53:1996;1162-1166.
26. Di Luca M., Pastorino L., Bianchetti A.et al. Differential pattern of platelet APP isoforms: an early marker for Alzheimer disease. Arch. Neurol. 55:1998;1195-1200.
27. Padovani A., Pastorino L., Borroni B.et al. Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD. Neurology. 57:2001;2243-2248.
28. Padovani A., Borroni B., Colciaghi C.et al. Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease. Arch. Neurol. 59:2002;71-75.
29. Thomas T. Beta amyloid mediated vasoactivity and vascular endothelial damage. Nature. 380:1996;168-171.
30. Borroni B., Colciaghi F., Pastorino L.et al. Amyloid precursor protein in platelets of patients with Alzheimer disease: effect of acetylcholinesterase inhibitor treatment. Arch. Neurol. 58(3):2001;442-446.
31. Mari D., Parnetti L., Coppola R.et al. Hemostasis abnormalities in patients with vascular dementia and Alzheimer's disease. Thromb. Haemost. 75(2):1996;216-218.
32. Sparks D.L. Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease? Ann. N.Y. Acad. Sci. 826:1997;128-146.
33. Kalaria R.N., Hedera P. β-Amyloid vasoactivity in Alzheimer's disease. Lancet. 347:1996;1492-1493.
34. Mancardi G.L., Perdelli F., Rivano C.et al. Thickening of the basement membrane of cortical capillaries in Alzheimer's disease. Acta Neuropathol. 49:1980;79-83.